$Apollo Global Management (APO.US)$ $SoftBank Group (ADR) (SFTBY.US)$
Apollo Global Management Inc. is planning to lend about $4 billion to SoftBank Group Corp., marking the biggest ever loan of its kind in the private credit market, according to people with knowledge of the matter.
The financing will be backed by holdings of SoftBank Vision Fund 2, which has made a range of equity investments in technology startups, the people added, asking not to be named discussing a private transaction. Terms are not yet final, but the $4 billion in borrowings would compare to the fund’s holdings of about $40 billion, one of the people said.
The interest rate on the loan is expected to be in the mid-single-digit percent range, the people added. Apollo, along with its insurance affiliate Athene Holding Ltd., are leading the deal, and a group of additional investors including mutual funds, endowments and financial institutions will also be part of the transaction, they said.
The loan comes during a period of relative turmoil at Masayoshi Son’s investment powerhouse, which is grappling with a spate of high-profile departures as well as a cratering of value in holdings from A $Alibaba (BABA.US)$ to $DiDi Global (Delisted) (DIDI.US)$. Global macroeconomic uncertainty and China’s crackdown on its biggest internet firms spurred a record loss at its Vision Fund unit during the September quarter. Its sale of Arm Ltd. to $NVIDIA (NVDA.US)$ is also in jeopardy, threatening a potential windfall of roughly $74 billion.
Still, the Japanese giant continues to sustain a rapid pace of deal-making. This month alone, SoftBank invested in Cerebral Inc., logistics startup Nowports and Latin America’s Addi, among others. Portfolio companies including India’s Snapdeal and Cohesity filed for initial public offerings or are in discussions for one. And SoftBank unveiled a 1 trillion yen ($9 billion) share buyback program just last month.

$AMC Entertainment (AMC.US)$ - stock breaking out on Friday with a lot of momentum. Added some swing calls. Looking for break of $33 first PT
$Galera Therapeutics (GRTX.US)$ -  last week Galera announced Primary Endpoint Met Statistical Significance In Corrected Topline Efficacy Data Of Phase 3 ROMAN Trial Of Avasopasem.
$Pfizer (PFE.US)$ - Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15. Can continue higher or break lower.
$Spruce Biosciences (SPRB.US)$ - Spruce Biosciences shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.

Completely agree. 3 years ago,
$Target (TGT.US)$ had a higher P/E than $Walmart (WMT.US)$ but it’s gone haywire. TGT is an earnings machine producing about 50% of the net profit WMT does on less than 20% of the revenue of WMT.

$Biora Therapeutics (PROG.US)$ big green candle!! Lets go!!

$American Virtual (AVCT.US)$ This is a company which is generating healthy revenues with Kandy & working with AT&T, IBM etc but it’s supposedly just a pump & dump.. stock market are just lacking investors & full of gamblers nowadays😂

$Pfizer (PFE.US)$ $AstraZeneca (AZN.US)$ An analysis of 581 cases of omicron infection showed that two doses of Either Astrazeneca or Pfizer vaccine provided much less protection against this strain than against the Delta strain. However, when given the Pfizer booster shot, patients who initially received the Astrazeneca vaccine had about 70% protection against symptomatic infections, compared with about 75% when initially given the Pfizer vaccine. By comparison, the booster vaccine was about 90% effective against the Delta strain.

$Tesla (TSLA.US)$ 1000 is definitely very strong support. When price dips below 1000, buyers come in and push back the price above